Benign Growth For CanSino Biologics Inc. (HKG:6185) Underpins Its Share Price

Simply Wall St.11-20

CanSino Biologics Inc.'s (HKG:6185) price-to-sales (or "P/S") ratio of 9.8x might make it look like a buy right now compared to the Biotechs industry in Hong Kong, where around half of the companies ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2584500188?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","is_english":true,"pubTime":"2025-11-20 09:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584500188","market":"hk","top_or_hot":-1,"title":"Benign Growth For CanSino Biologics Inc. (HKG:6185) Underpins Its Share Price","media":"Simply Wall St.","content":"<div>\n<p>CanSino Biologics Inc.'s (HKG:6185) price-to-sales (or \"P/S\") ratio of 9.8x might make it look like a buy right now compared to the Biotechs industry in Hong Kong, where around half of the companies ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6185/cansino-biologics-shares/news/benign-growth-for-cansino-biologics-inc-hkg6185-underpins-it\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Benign Growth For CanSino Biologics Inc. (HKG:6185) Underpins Its Share Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBenign Growth For CanSino Biologics Inc. (HKG:6185) Underpins Its Share Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-20 09:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6185/cansino-biologics-shares/news/benign-growth-for-cansino-biologics-inc-hkg6185-underpins-it><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>CanSino Biologics Inc.'s (HKG:6185) price-to-sales (or \"P/S\") ratio of 9.8x might make it look like a buy right now compared to the Biotechs industry in Hong Kong, where around half of the companies ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6185/cansino-biologics-shares/news/benign-growth-for-cansino-biologics-inc-hkg6185-underpins-it\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06185","symbol_name":"康希诺生物","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6185/cansino-biologics-shares/news/benign-growth-for-cansino-biologics-inc-hkg6185-underpins-it","article_id":"2584500188","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6185/cansino-biologics-shares/news/benign-growth-for-cansino-biologics-inc-hkg6185-underpins-it","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2584500188","pubTimestamp":1763601345,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"CanSino Biologics Inc.'s ( HKG:6185 ) price-to-sales (or \"P/S\") ratio of 9.8x might make it look like a buy right now...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"06185":"康希诺生物","BK1191":"制药","BK1515":"抗疫概念","BK1574":"生物医药B类股","BK1161":"生物科技"},"translate_title":"康希诺生物股份公司（HKG：6185）的良性增长支撑了其股价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06185":1.5},"content_text":"CanSino Biologics Inc.'s (HKG:6185) price-to-sales (or \"P/S\") ratio of 9.8x might make it look like a buy right now compared to the Biotechs industry in Hong Kong, where around half of the companies have P/S ratios above 13.4x and even P/S above 59x are quite common.   However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.    This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.  See our latest analysis for CanSino Biologics SEHK:6185 Price to Sales Ratio vs Industry November 20th 2025Advertisement What Does CanSino Biologics' P/S Mean For Shareholders?  CanSino Biologics could be doing better as it's been growing revenue less than most other companies lately.   The P/S ratio is probably low because investors think this lacklustre revenue performance isn't going to get any better.  If this is the case, then existing shareholders will probably struggle to get excited about the future direction of the share price.      If you'd like to see what analysts are forecasting going forward, you should check out our free report on CanSino Biologics.  Is There Any Revenue Growth Forecasted For CanSino Biologics?   CanSino Biologics' P/S ratio would be typical for a company that's only expected to deliver limited growth, and importantly, perform worse than the industry.   Retrospectively, the last year delivered an exceptional 30% gain to the company's top line.   However, this wasn't enough as the latest three year period has seen the company endure a nasty 49% drop in revenue in aggregate.  Therefore, it's fair to say the revenue growth recently has been undesirable for the company.     Looking ahead now, revenue is anticipated to climb by 35% per year during the coming three years according to the three analysts following the company.  With the industry predicted to deliver 89% growth each year, the company is positioned for a weaker revenue result.  With this information, we can see why CanSino Biologics is trading at a P/S lower than the industry.  It seems most investors are expecting to see limited future growth and are only willing to pay a reduced amount for the stock.    The Key Takeaway  Using the price-to-sales ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.  We've established that CanSino Biologics maintains its low P/S on the weakness of its forecast growth being lower than the wider industry, as expected.  Right now shareholders are accepting the low P/S as they concede future revenue probably won't provide any pleasant surprises.  The company will need a change of fortune to justify the P/S rising higher in the future.      Many other vital risk factors can be found on the company's balance sheet.  Take a look at our free balance sheet analysis for CanSino Biologics with six simple checks on some of these key factors.   It's important to make sure you look for a great company, not just the first idea you come across. So if growing profitability aligns with your idea of a great company, take a peek at this free list of interesting companies with strong recent earnings growth (and a low P/E). New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2584500188","isCrawlerRequest":true}